The timing of treatment in breast cancer: Gaps and delays in treatment can be harmful

Breast Cancer Research and Treatment

Volumn 60, Issue 3, 2000, Pages 201-209

  Johnson, Ann ^a,b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

'Split course' radiotherapy; Breast cancer; Growth rates; Histological grade; Primary medical treatment; Radiotherapy fractionation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MEDROXYPROGESTERONE; METHOTREXATE; MITOXANTRONE; TAMOXIFEN; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; CONTROLLED STUDY; FEMALE; HISTOLOGY; HORMONAL THERAPY; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REOXYGENATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033932941     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006441018271     Document Type: Article

References (23)

1. 1. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF: 'Residual' mammary carcinoma following simulated partial mastectomy. Cancer 35: 739-747, 1975
2. 2. Morgan DAL, Galea MH, Berridge J, Blamey RW, Elston CW, Ellis IO: Post-mastectomy radiotherapy in patients at high risk of locoregional recurrence: a randomized trial. The Breast 1: 151, 1992
3. 3. Dische S, Joslin CAF, Miller S, Bell NL, Holmes JC: The breast radiation injury litigation and the clinical oncologist. Clinical Oncology 10: 367-371, 1998
4. 4. Hewitt HB, Wilson CW: The effect of tissue oxygen tension on the radio-sensitivity of leukaemia cells irradiated in situ in the livers of leukaemic mice. Br J Cancer 13: 675-684, 1959
5. 5. Fowler JF, Morgan RL, Wood CAP: Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. I. The biological and physical advantages and problems of neutron therapy. Br J Radiol 36: 77-80, 1963
6. 6. Sumbrook, DK: Clinical trial of a modified ('split-course') technique of X-ray therapy in malignant tumours. Clin Radiol 13: 1-18, 1962
7. 7. Withers HR, Taylor JMG, Maciejewski B: The hazard of accelerated tumour clonogen repopulation during radiotherapy. Act Oncol 27: 131-146, 1988
8. 8. Fowler JF, Lindstrom MJ: Loss of local control with prolongation in radiotherapy. Int J Radiation Oncology Biol Phys 23: 457-467, 1992
9. 9. Saunders MI, Dische S: Continuous, hyperfractionated, acelerated radiotherapy (CHART). Sem Radiation Oncol 2: 41-44, 1992
10. 10. Johnson AE, Bennett MH, Cheung CWD, Cox SJ, Sales JELS: The management of individual breast cancers. The Breast 4: 100-111, 1995
11. 11. Cheung CWD, Johnson AE: Carcinoma of the breast: measurement and the management of treatment. II. The regression of tumours. Br J Radiol 64: 121-132, 1991
12. 12. Johnson AE, Shekhdar J: Interval cancers in the NHS breast screening programme. Br J Radiol 68: 862-869, 1995
13. 13. Orton, CG and Ellis F: A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol 46: 529-537, 1973
14. 14. Fowler JF: How worthwhile are short schedules in radiotherapy? A series of exploratory calculations. Radiother Oncol 18: 165-181, 1990
15. 15. Fowler JF: The phantom of tumour treatment - continually rapid proliferation unmasked. Radiother Oncol 22: 156-158, 1991
16. 16. Fowler JF: Modelling altered fractionation schedules. Br J Radiol Suppl 24: 187-192, 1992
17. 17. Cheung CWD, Johnson AE: Carcinoma of the breast: measurement and the management of treatment. I. The value of the data. Br J Radiol 64: 29-36, 1991
18. 18. Ashton-Key M, Campbell ID, Rew DA, Taylor I, Stradling R, Coddington R, Wilson GD: The histochemical evaluation of proliferation in breast carcinomas labelled in vivo with bromodeoxyuridine. The Breast 2: 42-47, 1993
19. 19. Steel GG: Growth kinetics of tumours. Clarendon Press, Oxford 1977, pp 40-52
20. 20. Johnson AE: Problems associated with randomized controlled clinical trials in breast cancer. J Eval Clin Pract 4: 119-126, 1998
21. 21. Johnson AE: Riposte to guest commentaries on 'Problems associated with randomized controlled clinical trials in breast cancer'. J Eval Clin Pract 4: 231-236, 1998
22. 22. Bennett MH: In vivo labelling of human tumours with bromodeoxyuridine: a histopathologist's view. Br J Radiol Suppl 24: 168-173, 1992
23. 23. Wilson GD, Dische S, Saunders MI: Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol 36: 189-197, 1995